A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
Sign Up to like & getrecommendations! Published in 2022 at "Hormone Research in Paediatrics"
DOI: 10.1159/000524244
Abstract: Introduction: LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH secretagogue receptor agonist under development for treatment of pediatric growth hormone deficiency (PGHD). Methods: The GH response to a single dose of LUM-201 and to… read more here.
Keywords: lum 201; responses standard; greater responses; secretagogue receptor ... See more keywords
9318 Growth Response To Oral Growth Hormone Secretagogue LUM-201 In Children With Moderate GH Deficiency (GHD) Is Dependent On The Pattern Of Pulsatile GH Secretion Induced By LUM-201
Sign Up to like & getrecommendations! Published in 2024 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvae163.1460
Abstract: Abstract Disclosure: A. Roslan: None. R. Roman: None. A. Avila: None. D. Said: None. I. Baier: None. E. Brincks: Employee; Self; Lumos Pharma, Inc.. Stock Owner; Self; Lumos Pharma, Inc. A. Bruchey: Employee; Self; Lumos… read more here.
Keywords: pharma inc; secretion; lum 201; lumos pharma ... See more keywords
SUN-092 Oral Growth Hormone Secretagogue (LUM-201) Pediatric Capsule Formulation Demonstrates Similar Pharmacokinetic (PK) Bioavailability and Pharmacodynamic (PD) Responses to Current Tablet Formulation
Sign Up to like & getrecommendations! Published in 2025 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaf149.1676
Abstract: Abstract Disclosure: E. Brincks: None. A. Parikh: Lumos Pharma, Inc. M. Quesnot: Lumos Pharma, Inc. C. Smith: Lumos Pharma, Inc. R. Christopher: Lumos Pharma, Inc. J. McKew: Lumos Pharma, Inc. P. Pitukcheewanont: Lumos Pharma, Inc.… read more here.
Keywords: formulation; pharma inc; capsule formulation; lum 201 ... See more keywords